Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Chlamydia pneumoniae-induced pathological signaling in the vasculature.

Kern JM, Maass V, Maass M.

FEMS Immunol Med Microbiol. 2009 Mar;55(2):131-9. doi: 10.1111/j.1574-695X.2008.00514.x. Review.

2.

Molecular pathogenesis of chronic Chlamydia pneumoniae infection: a brief overview.

Kern JM, Maass V, Maass M.

Clin Microbiol Infect. 2009 Jan;15(1):36-41. doi: 10.1111/j.1469-0691.2008.02631.x. Review.

3.

Chlamydia pneumoniae adversely modulates vascular cell properties by direct interaction with signalling cascades.

Kern JM, Maass V, Maass M.

Thromb Haemost. 2009 Dec;102(6):1064-70. doi: 10.1160/TH09-06-0348. Review.

PMID:
19967136
4.

Atherogenetically relevant cells support continuous growth of Chlamydia pneumoniae.

Maass M, Gieffers J, Solbach W.

Herz. 2000 Mar;25(2):68-72.

PMID:
10829241
5.

Chlamydia pneumoniae and atherosclerosis: the role of mast cells.

Di Pietro M, Schiavoni G, Del Piano M, Shaik Y, Boscolo P, Caraffa A, Grano M, Teté S, Conti F, Sessa R.

J Biol Regul Homeost Agents. 2009 Apr-Jun;23(2):65-9. Review.

PMID:
19589286
6.

Chronic perivascular inoculation with Chlamydophila pneumoniae results in plaque formation in vivo.

Engelmann MG, Redl CV, Pelisek J, Barz C, Heesemann J, Nikol S.

Lab Invest. 2006 May;86(5):467-76.

7.

[Chlamydia pneumoniae as a pathogenetic risk factor in the development of arteriosclerosis and its complications].

Nagornev VA, Mal'tseva SV, Seliverstova VG, Sokurenko GIu, Voskan'iants AN.

Arkh Patol. 2004 Mar-Apr;66(2):52-60. Russian.

PMID:
15154386
8.

[Chlamydia pneumoniae, atherosclerosis, and coronary disease].

Monno R, Di Biase M, Costi A, de Nicolò T, Correale M, Bolognese P, Losacco G.

Ital Heart J Suppl. 2003 May;4(5):383-97. Review. Italian.

PMID:
12848076
9.

Advances in the management of Chlamydia pneumoniae infections.

Hammerschlag MR.

Expert Rev Anti Infect Ther. 2003 Oct;1(3):493-503. Review.

PMID:
15482145
10.

Chlamydia pneumoniae and atherosclerosis: does the evidence support a causal or contributory role?

Mahony JB, Coombes BK.

FEMS Microbiol Lett. 2001 Apr 1;197(1):1-9. Review.

11.

Possibilities for therapeutic interventions in disrupting Chlamydophila pneumoniae involvement in atherosclerosis.

Deniset JF, Pierce GN.

Fundam Clin Pharmacol. 2010 Oct;24(5):607-17. doi: 10.1111/j.1472-8206.2010.00863.x. Review.

PMID:
20653790
12.

Detection of Chlamydia pneumoniae in atherosclerotic plaques of patients in Tehran, Iran.

Dabiri H, Rezadehbashi M, Badami N, Aghanouri R, Ahmadi H, Khoramizadeh MR, Emaneini M, Izadi M, Zali MR.

Jpn J Infect Dis. 2009 May;62(3):195-7.

13.

Silencing or permanent activation: host-cell responses in models of persistent Chlamydia pneumoniae infection.

Peters J, Hess S, Endlich K, Thalmann J, Holzberg D, Kracht M, Schaefer M, Bartling G, Klos A.

Cell Microbiol. 2005 Aug;7(8):1099-108.

PMID:
16008577
14.

[The implication of Chlamydia pneumoniae in damage to human aortic endotheliocytes in atherosclerosis].

Lysenko AI, Solov'eva NA.

Arkh Patol. 2010 Mar-Apr;72(2):21-5. Russian.

PMID:
20698311
15.

Persistent C. pneumoniae infection in atherosclerotic lesions: rethinking the clinical trials.

Campbell LA, Rosenfeld ME.

Front Cell Infect Microbiol. 2014 Mar 21;4:34. doi: 10.3389/fcimb.2014.00034. eCollection 2014. Review. No abstract available.

16.

Apolipoprotein E4 enhances attachment of Chlamydophila (Chlamydia) pneumoniae elementary bodies to host cells.

Gérard HC, Fomicheva E, Whittum-Hudson JA, Hudson AP.

Microb Pathog. 2008 Apr;44(4):279-85. Epub 2007 Oct 18.

PMID:
17997273
17.

Chlamydophila pneumoniae. Mechanisms of target cell infection and activation.

Krüll M, Maass M, Suttorp N, Rupp J.

Thromb Haemost. 2005 Aug;94(2):319-26. Review.

PMID:
16113821
18.

Atherogenic effects of Chlamydia pneumoniae: refuting the innocent bystander hypothesis.

Selzman CH, Netea MG, Zimmerman MA, Weinberg A, Reznikov LL, Grover FL, Dinarello CA.

J Thorac Cardiovasc Surg. 2003 Sep;126(3):688-93.

PMID:
14502140
19.

Chlamydia pneumoniae infection acts as an endothelial stressor with the potential to initiate the earliest heat shock protein 60-dependent inflammatory stage of atherosclerosis.

Kreutmayer S, Csordas A, Kern J, Maass V, Almanzar G, Offterdinger M, Öllinger R, Maass M, Wick G.

Cell Stress Chaperones. 2013 May;18(3):259-68. doi: 10.1007/s12192-012-0378-7. Epub 2012 Nov 29.

20.

Inhibition of apoptosis in neuronal cells infected with Chlamydophila (Chlamydia) pneumoniae.

Appelt DM, Roupas MR, Way DS, Bell MG, Albert EV, Hammond CJ, Balin BJ.

BMC Neurosci. 2008 Jan 24;9:13. doi: 10.1186/1471-2202-9-13.

Supplemental Content

Support Center